Decitabine-cedazuridine as first line in acute myeloid leukaemia ineligible for conventional induction chemotherapy

Bull Cancer. 2024 Apr 5:S0007-4551(24)00081-X. doi: 10.1016/j.bulcan.2024.01.012. Online ahead of print.NO ABSTRACTPMID:38582741 | DOI:10.1016/j.bulcan.2024.01.012

Source: Bulletin du Cancer - April 6, 2024 Category: Cancer & Oncology Authors: Urbain Tauveron-Jalenques Juliette Lambert Source Type: research